Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Douglas Yee

Showing results (11-20 of 187) with videos related to

Pageof 19
Sort By:
Cancer Research|August 3, 2002
Insulin-like growth factor binding protein-1 (IGFBP-1) inhibits breast cancer cell motilityXihong Zhang, Douglas Yee
International Journal of Molecular Sciences|January 12, 2021
Disrupting Insulin and IGF Receptor Function in CancerJingran Cao, Douglas Yee
Current Breast Cancer Reports|December 14, 2020
I-SPY 2: a Neoadjuvant Adaptive Clinical Trial Designed to Improve Outcomes in High-Risk Breast CancerHaiyun Wang, Douglas Yee
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 7, 2006
Is the type I insulin-like growth factor receptor a therapeutic target in endometrial cancer?Hua Zhang, Douglas Yee
Molecular Cancer Therapeutics|January 24, 2007
Disrupting insulin-like growth factor signaling as a potential cancer therapyDeepali Sachdev, Douglas Yee
Future Oncology (London, England)|March 25, 2006
Targeting the insulin-like growth factor axis as a cancer therapyTufia Haddad, Douglas Yee
Journal of Mammary Gland Biology and Neoplasia|September 2, 2006
Inhibitors of insulin-like growth factor signaling: a therapeutic approach for breast cancerDeepali Sachdev, Douglas Yee
Breast Disease|February 3, 2005
The type I IGF receptor as a target for breast cancer therapyXihong Zhang, Douglas Yee
Endocrinology|July 25, 2021
The Emerging Role of the Fetal Insulin Receptor in Hormone-refractory Breast CancerTanvi Mathur, Douglas Yee
Advances in Experimental Medicine and Biology|November 13, 2007
Insulin-like growth factors and breast cancer therapyXianke Zeng, Douglas Yee
Pageof 19

Showing results (11-20 of 187) with videos related to

Sort By:
Pageof 19
Cancer Research|August 3, 2002
Insulin-like growth factor binding protein-1 (IGFBP-1) inhibits breast cancer cell motilityXihong Zhang, Douglas Yee
International Journal of Molecular Sciences|January 12, 2021
Disrupting Insulin and IGF Receptor Function in CancerJingran Cao, Douglas Yee
Current Breast Cancer Reports|December 14, 2020
I-SPY 2: a Neoadjuvant Adaptive Clinical Trial Designed to Improve Outcomes in High-Risk Breast CancerHaiyun Wang, Douglas Yee
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 7, 2006
Is the type I insulin-like growth factor receptor a therapeutic target in endometrial cancer?Hua Zhang, Douglas Yee
Molecular Cancer Therapeutics|January 24, 2007
Disrupting insulin-like growth factor signaling as a potential cancer therapyDeepali Sachdev, Douglas Yee
Future Oncology (London, England)|March 25, 2006
Targeting the insulin-like growth factor axis as a cancer therapyTufia Haddad, Douglas Yee
Journal of Mammary Gland Biology and Neoplasia|September 2, 2006
Inhibitors of insulin-like growth factor signaling: a therapeutic approach for breast cancerDeepali Sachdev, Douglas Yee
Breast Disease|February 3, 2005
The type I IGF receptor as a target for breast cancer therapyXihong Zhang, Douglas Yee
Endocrinology|July 25, 2021
The Emerging Role of the Fetal Insulin Receptor in Hormone-refractory Breast CancerTanvi Mathur, Douglas Yee
Advances in Experimental Medicine and Biology|November 13, 2007
Insulin-like growth factors and breast cancer therapyXianke Zeng, Douglas Yee
Pageof 19